At a glance
Read the record in context
Ibutamoren's non-peptide identity is intentionally visible within this broad library. The oral route and absent vial field prevent the page from looking like an injection-preparation guide. MK-677 is an alternate name for the same record, not a second package or a different unit.[1]
What the research says
The cited discovery paper studied MK-677, then called L-163,191, as an orally active growth hormone secretagogue. Initial experiments measured growth hormone release from cultured rat pituitary cells. Animal work then examined oral administration in dogs, connecting laboratory activity with exposure through the gastrointestinal route.[2]
The investigators measured growth hormone alongside several other circulating hormones, including cortisol, prolactin, thyroid hormone, and luteinizing hormone. This helped characterize endocrine selectivity in the animal experiments. The paper describes a non-peptide structural class, despite its biological relationship to peptide secretagogues.[2]
The source concluded with selection of the compound for clinical development. It is therefore preclinical discovery evidence, not a human pharmacokinetic study establishing the library's 24-hour scalar. The oral identity is retained, and no powder-vial conversion is inferred from the fact that it appears among peptide-related guides.[2][1]
Cited amounts
The library does not supply a typical vial amount for this entry. This guide therefore reports no vial total or human dosing range and does not infer one from the half-life.[1]
Open the calculator for amount conversionsHalf-life and timing
A 24-hour scalar aligns the illustrated halvings with successive days. The model retains 25% at 48 hours, 12.5% at 72 hours, and 3.125% at 120 hours. The daily spacing is a result of the library input, not a recommendation for taking an oral product daily. An oral absorption process and repeated entries are absent from this simple sequence. A five-day plotting window therefore cannot establish a personal elimination interval or turn the research citation into a dosing schedule.[1][4]
Continue to the calculatorReconstitution
There is no documented ibutamoren vial total to substitute into a liquid-concentration equation. In particular, the library's oral description does not supply a volume of reconstitution solution. A numerical example pretending otherwise would hide a missing input. The useful calculation boundary is explicit: mass divided by an independently known liquid volume gives concentration, but a compound name and a half-life cannot supply that denominator. This guide therefore offers the general calculator without proposing to dissolve or reformulate an oral presentation.[1]
Tracking it in PinPoint
From a reference to a record
Built for peptide, TRT, and GLP-1 schedules. Set up your vial in seconds, log every dose, and see your modeled levels between doses. Enter vial size in mg, mcg, or IU and water volume for instant concentration and syringe units. Track vials and prefilled pens side by side.[3]
The Home curve models your levels between doses from published half-life data. Drag to scrub modeled values at any timestamp, or preview 30 days of a dose pattern. Ask PinPoint provides educational reference with sources; it never recommends a dose or a schedule change. These features record and visualize entered information, with the limits of each compound's source data still applying.
Get PinPoint on the App StoreFrequently asked questions
- Is MK-677 an injectable peptide reconstitution example?
- The library describes ibutamoren as an orally active non-peptide compound. No typical vial is recorded. Its inclusion in the reference list supports identifying and tracking the compound, not converting an oral formulation into a powder-vial preparation.[1][2]
- What does the name MK-677 add to an ibutamoren record?
- It helps identify the orally active non-peptide compound described by the library. It does not supply an amount, package volume, or preparation method. Those quantities would still require their own independently known source.[1][4]
- Why does this ibutamoren page omit a vial-mixing example?
- The source record has no typical vial and specifies oral use in its description. Inventing a powder package would add an unsupported fact. The absence is therefore preserved rather than filled with a standard-looking peptide example.[1][4]
- Can a peptide tracker app record Ibutamoren?
- PinPoint's compound library includes Ibutamoren. The app description covers logging compound, dose, site, and pain level, as well as viewing modeled levels between recorded doses. The curve uses published reference inputs and does not account for individual variation. The tracker records the schedule entered by its user; it does not choose a dose or recommend a schedule change.[1][3]
Sources
Facts and reference links were retrieved from the PinPoint application library on 5 October 2026. Links below preserve the library's citations; a catalog source supports a package amount only. Source references carried from the library have not all been independently reverified. Arithmetic examples are identified separately from clinical evidence.
- PinPoint compound library, IbutamorenSnapshot of the application library; its references and uncertainty are retained below.Retrieved 2026-10-05 · library
- PubMed pharmacology reference 7624358Identity and research summary checked against this document on 5 October 2026. PubMed abstract, retrieved through NCBI EFetch.Retrieved 2026-10-05 · library-reference
- PinPoint App Store descriptionFeature wording from the approved application description, not pricing.Retrieved 2026-10-05 · app-description
- Unit conversion and exponential-decay arithmeticC = amount / volume; remaining fraction = 2^(-elapsed / half-life). These are illustrations, not measurements.Retrieved 2026-10-05 · arithmetic